Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | GCK | P35557 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1498788 | 0.88 | P2RY1 (0.41) | P2RY1MEN1ALDH1A1LMNAMAPT | |
| SCHEMBL3215788 | 0.88 | P2RY1 (0.41) | P2RY1MEN1ALDH1A1LMNAMAPT | |
| SCHEMBL12831919 | 0.86 | P2RY1 (0.39) | P2RY1SLC22A12HTR2AHTR2CHTR2B | |
| SCHEMBL3209143 | 0.86 | P2RY1 (0.39) | P2RY1MEN1ALDH1A1LMNAMAPT | |
| SCHEMBL30947421 | 0.77 | CAMK2A (0.46) | MEN1ALDH1A1LMNAMAPTHPGD | |
| SCHEMBL3210311 | 0.75 | P2RY1 (0.39) | P2RY1MEN1ALDH1A1LMNAMAPT | |
| SCHEMBL30433942 | 0.73 | L3MBTL1 (0.50) | MEN1ALDH1A1MAPTHPGDMAPK1 | |
| SCHEMBL6545410 | 0.72 | ADORA2A (0.50) | ALDH1A1SLC22A12GCK | |
| SCHEMBL3198498 | 0.72 | P2RX3 (0.39) | P2RY1KDM4E | |
| SCHEMBL13486201 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240251654-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2024-07-25 | — | — | US | claimed |
| EP-4485092-B1 | SYSTEMS AND METHODS FOR EXPLAINING ALARMS RAISED BY MACHINE LEARNED MODELS OF INDUSTRIAL AUTOMATION SYSTEMS | ABB SCHWEIZ AG (CH) | 2026-04-08 | — | — | EP | disclosed |
| US-20250004464-A1 | Systems and Methods for Explaining Alarms Raised by Machine Learned Models of Industrial Automation Systems | ABB SCHWEIZ AG (CH) | 2025-01-02 | — | — | US | disclosed |
| US-20250003976-A1 | ANTIBODIES TARGETING PHOSPHORYLATED SEVEN-TRANSMEMBRANE RECEPTORS | 7TM ANTIBODIES GMBH (DE) | 2025-01-02 | — | — | US | disclosed |
| EP-4485092-A1 | SYSTEMS AND METHODS FOR EXPLAINING ALARMS RAISED BY MACHINE LEARNED MODELS OF INDUSTRIAL AUTOMATION SYSTEMS | ABB SCHWEIZ AG (CH) | 2025-01-01 | — | — | EP | disclosed |
| CN-119225293-A | System and method for interpreting alarms raised by machine learning models of industrial automation systems | ABB瑞士股份有限公司 | 2024-12-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240251654-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | LEF1, EFNA1, EML4 | P2RY1 1263/4885MEN1 1476/4885ALDH1A1 131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.